A new market study highlights the transformative potential of the global RNA-Based Cardiac Therapeutics Market forecasting a period of unparalleled growth between 2025 and 2032. The market, which leverages advanced nucleic acid technologies to treat cardiovascular diseases (CVDs) at the genetic level, is poised to redefine standards of care for heart failure, hypercholesterolemia, and... https://www.databridgemarketresearch.com/